High expression of SLFN5 in melanoma (6), renal cell carcinoma (27), and breast cancer inhibits tumor invasion and migration (28), indicating that SLFN5 acts as a tumor suppressor gene. This evidence concerns the gene SLFN5 and neoplasm.